Intraneuronal signalling systems as targets for the development of novel mood-stabilizing drugs.
Wachtel
H
H
Schering AG, Berlin, F.R.G.
D000339:Affect / Q000187:drug effects*; D000818:Animals; D006801:Humans; D009474:Neurons / Q000187:drug effects*; D015290:Second Messenger Systems / Q000187:drug effects; D015398:Signal Transduction / Q000187:drug effects*